26 September 2022 · All calcium channel blockers may cause peripheral oedema. There are different treatment options and the incidence can be affected by different factors.
21 September 2022 · Safety risks and mitigation strategies are described to reduce the risk of errors with intravenous paracetamol in neonates, infants, and children.
7 September 2022 · Healthcare professionals who use vitamin D should be aware of the risks of toxicity and safe practice principles which may prevent patient harm
7 September 2022 · Healthcare professionals involved in the use of metolazone need to be aware of the differences between licensed and unlicensed products to ensure safe care.
11 August 2022 · Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Phenol products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Ropivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Baclofen products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration